Josephine Schambelan
Family Medicine · Hewitt, NJNPI 1922607316
Payments from drug & device makers
Across 156 payments — averaging $15.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$835
- AbbVie$452
- Bausch Health US, LLC$270
- Exact Sciences$212
- Merck$83
- Lilly USA, LLC$78
- plus $448 from 16 others
What the payments were for
- Food & beverage$2,378100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 55 | $835 |
| AbbVie | 34 | $452 |
| Bausch Health US, LLC | 23 | $270 |
| Exact Sciences | 7 | $212 |
| Merck | 5 | $83 |
| Lilly USA, LLC | 5 | $78 |
| Insulet Corporation | 3 | $67 |
| Astellas Pharma US Inc | 3 | $65 |
| Pfizer | 3 | $46 |
| Dexcom, Inc. | 1 | $31 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Eisai Inc. | 2 | $30 |
| Boehringer Ingelheim | 2 | $28 |
| Azurity Pharmaceuticals, Inc. | 2 | $28 |
| Vistapharm, Inc. | 2 | $25 |
| Sanofi Pasteur Inc. | 1 | $16 |
| AstraZeneca | 1 | $15 |
| Novartis | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| GE HealthCare | 1 | $14 |
| GSK | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $13 |
How this compares
$2,378 in reported general payments places this provider in the 75th percentile of 2,084 family medicine providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 19 | $17,990 |
| JanuviaSitagliptin Phosphate | 16 | $17,395 |
| JardianceEmpagliflozin | 12 | $6,123 |
| Atorvastatin Calcium | 104 | $1,113 |
| Levothyroxine Sodium | 107 | $931 |
| SynthroidLevothyroxine Sodium | 11 | $779 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 12 | $762 |
| Amlodipine Besylate | 65 | $618 |
| Metoprolol Succinate | 46 | $457 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 52 | $426 |
| Fluticasone Propionate | 17 | $412 |
| Methylprednisolone | 73 | $406 |
| Gabapentin | 21 | $393 |
| Losartan Potassium | 37 | $393 |
| Simvastatin | 29 | $347 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $46 | $17,99019 claims |
| MerckJanuvia | $83 | $17,39516 claims |
| Boehringer IngelheimJardiance | $28 | $6,12312 claims |
| AbbVieSynthroid | $452 | $77911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,084 family medicine providers in New Jersey.
Other family medicine in Hewitt
- Howard HassmanClementon$47.1M
- Matthew HongNorth Cape May$15.3M
- Rubaba HussainClark$3.8M
- Gaurang BrahmbhattHoboken$2.6M
- Michael DobrowClifton$2.1M
- Mikhail VarshavskiChatham$1.4M
- Amit BhalodiaCamden$707K
- Jennifer AmicoNew Brunswick$627K
- Janet ColeFar Hills$466K
- Matthew PintoMarlton$239K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.